ZEKE CAPITAL ADVISORS, LLC - ACCELERON PHARMA INC ownership

ACCELERON PHARMA INC's ticker is XLRN and the CUSIP is 00434H108. A total of 258 filers reported holding ACCELERON PHARMA INC in Q4 2020. The put-call ratio across all filers is 0.78 and the average weighting 0.4%.

Quarter-by-quarter ownership
ZEKE CAPITAL ADVISORS, LLC ownership history of ACCELERON PHARMA INC
ValueSharesWeighting
Q3 2021$443,000
+34.2%
2,573
-2.2%
0.03%
+23.8%
Q2 2021$330,000
+1.2%
2,632
+9.4%
0.02%
-8.7%
Q1 2021$326,000
+5.8%
2,4060.0%0.02%
-8.0%
Q4 2020$308,000
+28.9%
2,406
+13.3%
0.02%
-10.7%
Q3 2020$239,000
-61.8%
2,124
-82.0%
0.03%
-46.2%
Q4 2019$625,000
+6.8%
11,793
-20.3%
0.05%0.0%
Q3 2019$585,000
-3.8%
14,7960.0%0.05%
-8.8%
Q2 2019$608,000
-26.2%
14,796
-16.4%
0.06%
-26.0%
Q1 2019$824,000
-18.5%
17,693
-23.8%
0.08%
-20.6%
Q4 2018$1,011,000
-18.3%
23,207
+7.3%
0.10%
-4.0%
Q3 2018$1,238,00021,6250.10%
Other shareholders
ACCELERON PHARMA INC shareholders Q4 2020
NameSharesValueWeighting ↓
Polaris Venture Management Co IV LLC 1,480,060$53,563,00085.86%
NEXTHERA CAPITAL LP 217,817$7,883,0004.84%
Novo Holdings A/S 903,833$32,710,0002.90%
SECTORAL ASSET MANAGEMENT INC 481,765$17,435,0001.71%
Perceptive Advisors 589,890$21,348,0001.38%
RA Capital Management 318,565$11,529,0001.19%
OAK RIDGE INVESTMENTS LLC 1,226,468$44,386,0001.15%
Granahan Investment Management 817,149$29,573,0000.97%
Eventide Asset Management 428,900$15,522,0000.95%
QVT Financial LP 636,764$23,044,0000.87%
View complete list of ACCELERON PHARMA INC shareholders